State
73,817 recalls have nationwide distribution and so reach US Virgin Islands. 178 additional recalls listed US Virgin Islands specifically in their distribution scope.
Of the 178 recalls naming US Virgin Islands we have scored against our rubric, 12 (7%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 39 (22%) are Severe.
Which agencies issued them
These figures cover only the 178 recalls whose distribution notice names US Virgin Islands specifically. The 73,817 nationwide recalls listed below reach every state, so counting them here would make every state page show the same numbers.
Rainbow Play Systems is recalling yellow plastic trapeze rings that can crack or break, posing a fall hazard to children.
Chrysler is recalling 2016 Town and Country and Dodge Grand Caravan minivans because hood striker bolts may loosen, allowing the hood to open while driving.
Fujitsu America is recalling specific lithium-ion battery packs for notebook computers because they can overheat and catch fire. Consumers should remove the battery and contact Fujitsu for a free replacement.
E-One is recalling 2013-2014 Typhoon, Cyclone II, and Quest emergency vehicles because loose front suspension ball joints could separate, causing loss of steering control.
Wishbone Design is recalling Recycled Edition Bikes because the handlebar can pinch fingers. The company reported four incidents, including two injuries requiring medical attention.
Pride Family Brands is recalling Bed Bath & Beyond Destination Summer Hammock Stands because the Z-shaped hooks can bend or break, causing consumers to fall.
Lippert is recalling Coachstep Double and Triple Electric Steps because a bolt may fracture, causing the steps to become unstable and increasing the risk of injury.
SynCardia Systems is recalling Freedom Drivers because a component may fail, causing the drive mechanism to stop pumping and resulting in the loss of life-sustaining function.
The Compounding Pharmacy of America is recalling Fentanyl and Bupivacaine Intrathecal Solution due to FDA inspection findings of GMP violations that may impact sterility.
The Compounding Pharmacy of America is recalling Testosterone 70 mg sterile pellets due to FDA inspection findings of GMP violations that may impact sterility.
FCA is recalling 2016 Ram 2500, 3500, 4500, and 5500 trucks because a short circuit in the Engine Control Module may cause the engine to stall without warning, increasing crash risk.
The Compounding Pharmacy of America is recalling Fentanyl and Bupivacaine Intrathecal Solution due to FDA inspection findings of GMP violations that may impact sterility.
The Compounding Pharmacy of America is recalling Estradiol 15 mg sterile pellets nationwide because FDA inspections identified GMP violations affecting sterility.
The Compounding Pharmacy of America is recalling Hydromorphone and Bupivacaine Intrathecal Solution due to FDA inspection findings of GMP violations that may impact sterility.
The Compounding Pharmacy of America is recalling Tri-Mix Super Injectable vials because FDA inspections found violations that may affect sterility.
The Compounding Pharmacy of America is recalling Sufentanil and Bupivacaine solution because FDA inspections found violations that may have compromised sterility.
The Compounding Pharmacy of America is recalling PGE 40 (Alprostadil) 40 mcg/ml Injection due to FDA inspection findings of GMP violations that may impact sterility.
The Compounding Pharmacy of America is recalling specific lots of compounded intrathecal solution due to FDA inspection findings of GMP violations that may impact sterility.
The Compounding Pharmacy of America is recalling Baclofen 1,000 mcg/ml Intrathecal Solution due to FDA inspection findings of GMP violations that may impact sterility.
The Compounding Pharmacy of America is recalling Morphine 40 mg/ml Solution due to FDA inspection findings of GMP violations that may impact sterility.
The Compounding Pharmacy of America is recalling a specific intrathecal solution because an FDA inspection found GMP violations that may affect sterility.
The Compounding Pharmacy of America is recalling Tri-Mix injectable products due to FDA inspection findings of GMP violations that impact sterility.
The Compounding Pharmacy of America is recalling Testosterone 87.5 mg Sterile Pellets because FDA inspections identified GMP violations that may impact sterility.
The Compounding Pharmacy of America is recalling compounded intrathecal solution due to FDA inspection findings of GMP violations that impact sterility assurance.
The Compounding Pharmacy of America is recalling Tri-Mix AT-6 Injectable due to FDA inspection findings of GMP violations that may impact sterility.